Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis
Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC
Racial Disparities Persist In Diagnosis Of Advanced Breast Cancer, Colon Cancer
Breast Cancer Rates Decline Most for Affluent White Women
Low Prevalence Of Tamoxifen Use For Cancer Prevention
Symptoms Don’t Help Detect Early-Stage Ovarian Cancer
Two-Week Break Balances RT Palliation, Side Effects
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- No need for a speculum? A new era of HPV screening
- Most Favored Nation drug pricing could put China on top
- Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line









